MHTX Stock Overview
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Manhattan Scientifics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.002 |
| 52 Week High | US$0.0089 |
| 52 Week Low | US$0.001 |
| Beta | 1.28 |
| 1 Month Change | -35.48% |
| 3 Month Change | -13.04% |
| 1 Year Change | -62.26% |
| 3 Year Change | -93.33% |
| 5 Year Change | -86.67% |
| Change since IPO | -80.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MHTX | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 42.9% | 0.5% | -0.7% |
| 1Y | -62.3% | 1.2% | 22.8% |
Return vs Industry: MHTX underperformed the US Biotechs industry which returned 0.1% over the past year.
Return vs Market: MHTX underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| MHTX volatility | |
|---|---|
| MHTX Average Weekly Movement | 63.2% |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MHTX's share price has been volatile over the past 3 months.
Volatility Over Time: MHTX's weekly volatility has increased from 44% to 63% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1 | Manny Tsoupanarias | www.mhtx.com |
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications.
Manhattan Scientifics, Inc. Fundamentals Summary
| MHTX fundamental statistics | |
|---|---|
| Market cap | US$1.12m |
| Earnings (TTM) | -US$1.16m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.0x
P/E RatioIs MHTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MHTX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$1.17m |
| Earnings | -US$1.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -3.3% |
How did MHTX perform over the long term?
See historical performance and comparison